Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study (INSIGHT 006: FLU-IVIG)
2014-004271-22Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Nov 2014
- Modality
- Anti-infectious Disease mAbs → Neutralizing Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of FLU-IGIV in influenza, sponsored by University of Minnesota. Started Nov 2014; status: completed.
02
Drugs
FLU-IGIV
03
Conditions
influenza
Beyond the preview
Go deeper on 2014-004271-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004271-22.